Vanguard Group Inc Bioventus Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Bioventus Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,924,788 shares of BVS stock, worth $21.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,924,788
Previous 2,802,039 4.38%
Holding current value
$21.5 Million
Previous $18.5 Million 5.48%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$6.14 - $7.64 $753,678 - $937,802
122,749 Added 4.38%
2,924,788 $19.6 Million
Q2 2025

Aug 11, 2025
BUY
$6.2 - $9.51 $1.54 Million - $2.36 Million
247,815 Added 9.7%
2,802,039 $18.5 Million
Q1 2025

May 09, 2025
BUY
$8.76 - $11.05 $807,172 - $1.02 Million
92,143 Added 3.74%
2,554,224 $23.4 Million
Q4 2024

Feb 11, 2025
BUY
$10.5 - $13.71 $4.08 Million - $5.32 Million
388,174 Added 18.72%
2,462,081 $25.9 Million
Q3 2024

Nov 13, 2024
BUY
$5.73 - $11.95 $2.37 Million - $4.94 Million
413,241 Added 24.88%
2,073,907 $24.8 Million
Q2 2024

Aug 13, 2024
BUY
$3.96 - $6.93 $1.75 Million - $3.06 Million
442,166 Added 36.29%
1,660,666 $9.55 Million
Q4 2023

Feb 14, 2024
BUY
$2.89 - $5.34 $50,343 - $93,022
17,420 Added 1.45%
1,218,500 $6.42 Million
Q3 2023

Nov 14, 2023
BUY
$2.8 - $4.94 $15,870 - $27,999
5,668 Added 0.47%
1,201,080 $3.96 Million
Q2 2023

Aug 14, 2023
SELL
$0.93 - $3.64 $126,498 - $495,112
-136,020 Reduced 10.22%
1,195,412 $3.45 Million
Q1 2023

May 15, 2023
SELL
$1.07 - $2.95 $15,941 - $43,952
-14,899 Reduced 1.11%
1,331,432 $1.42 Million
Q4 2022

Feb 10, 2023
BUY
$1.81 - $8.14 $293,989 - $1.32 Million
162,425 Added 13.72%
1,346,331 $3.51 Million
Q3 2022

Nov 14, 2022
BUY
$6.54 - $9.08 $1.25 Million - $1.74 Million
191,671 Added 19.32%
1,183,906 $8.29 Million
Q2 2022

Aug 12, 2022
SELL
$6.82 - $13.82 $878,613 - $1.78 Million
-128,829 Reduced 11.49%
992,235 $6.77 Million
Q1 2022

May 13, 2022
SELL
$11.65 - $15.28 $5.07 Million - $6.65 Million
-435,365 Reduced 27.97%
1,121,064 $15.8 Million
Q4 2021

Feb 14, 2022
BUY
$12.37 - $16.77 $9.31 Million - $12.6 Million
752,650 Added 93.64%
1,556,429 $22.6 Million
Q3 2021

Nov 12, 2021
BUY
$13.7 - $17.25 $3.92 Million - $4.94 Million
286,286 Added 55.32%
803,779 $11.4 Million
Q2 2021

Aug 13, 2021
BUY
$13.75 - $18.8 $7.12 Million - $9.73 Million
517,493 New
517,493 $9.11 Million

About Bioventus Inc.

BVS Quotes by TradingView
  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $453M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email